A Multicenter Randomized Trial Comparing IM Nails and Plate Fixation in Distal Femur Fractures

NCT ID: NCT00429663

Last Updated: 2017-05-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-02-28

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study looks at two (2) types of surgical treatments and hopes to answer the question, "which is the best way to surgically treat a distal femur fracture?" Both procedures being studied are standard of care (used routinely) and use FDA approved devices. All medical and surgical treatment will be the same for participants as non-participants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a randomized controlled multicenter trial in which individuals sustaining a fracture of the supracondylar (metaphyseal) region of the distal femur will be operatively managed by one of two strategies. The first strategy involves fixation of the fracture with a reamed, interlocking intramedullary nail (Nail Group). The second treatment strategy involves open reduction and internal fixation of the fracture with a locking periarticular plate (Plate Group). The null hypothesis of the study is that there will be no difference in the two groups with respect to the primary and secondary outcome measures. To the degree possible, patients in the two groups will receive post-operative care according to the same standards and protocols.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoral Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IM Nails

Reamed, Interlocking Intramedullary Nail - Randomized treatment

Group Type OTHER

reamed, interlocking intramedullary nail

Intervention Type DEVICE

Standard of care device for femur fracture repair

Plate Fixation

Locking Periarticular Plate - Randomized Treatment

Group Type OTHER

locking periarticular plate

Intervention Type DEVICE

Standard of care device for femur fractures

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

reamed, interlocking intramedullary nail

Standard of care device for femur fracture repair

Intervention Type DEVICE

locking periarticular plate

Standard of care device for femur fractures

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Skeletally mature
* Fracture of the metaphyseal distal femur with or without intra-articular extension and with or without a TKA
* Fracture requiring operative treatment amenable to either IM nail or plate
* Informed consent obtained
* Patient is English speaking

Exclusion Criteria

* Fracture of the metaphyseal distal femur with intra-articular communition,
* Fracture with vascular injury (Gustillo Type IIIC injury) requiring repair,
* Pathological fracture,
* Known metabolic bone disease,
* Contralateral distal femur fractures (bilateral injury) or ipsilateral lower extremity injury that would compromise function of the knee
* Retained hardware or existing deformity in the affected limb that would complicate IM nailing or plating
* Symptomatic knee arthritis
* Soft tissue injuries compromising either treatment method with nail or plate
* Surgical delay greater than 3 weeks for closed fractures or 24 hours for open fractures
* Immunocompromised
* Unable to comply with postoperative rehabilitation protocols or instructions (i.e. head injured or mentally impaired)
* Current or impending incarceration
* Unlikely to follow-up in surgeon's estimation
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paul Tornetta, III, M.D.

Paul Tornetta,III,M.D

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul Tornetta, M.D.

Role: PRINCIPAL_INVESTIGATOR

Boston University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California - Davis

Sacramento, California, United States

Site Status

Tampa General Hospital

Tampa, Florida, United States

Site Status

Indiana University

Indianapolis, Indiana, United States

Site Status

University of Maryland Medical Center

Baltimore, Maryland, United States

Site Status

Boston Medical Center

Boston, Massachusetts, United States

Site Status

UMass Memorial Medical Center

Worchester, Massachusetts, United States

Site Status

University of Michigan Hospital

Ann Arbor, Michigan, United States

Site Status

Orthopaedic Associates of Michigan

Grand Rapids, Michigan, United States

Site Status

Hennepin County Medical Center

Minneapolis, Minnesota, United States

Site Status

St. Mary's Hospital - Mayo Clinic

Rochester, Minnesota, United States

Site Status

Barnes Hospital

St Louis, Missouri, United States

Site Status

St. Louis University Hospital

St Louis, Missouri, United States

Site Status

Cooper University Hospital

Camden, New Jersey, United States

Site Status

New York Hospital for Joint Diseases

New York, New York, United States

Site Status

University of Rochester Medical Center

Rochester, New York, United States

Site Status

Ohio State University Medical Center

Columbus, Ohio, United States

Site Status

University of Oklahoma/ Health Science

Oklahoma City, Oklahoma, United States

Site Status

Oregon Health and Sciences University

Portland, Oregon, United States

Site Status

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

Site Status

Campbell Foundation

Memphis, Tennessee, United States

Site Status

Orthopaedic Specialty Associates Fort Worth

Fort Worth, Texas, United States

Site Status

Harborview Medical Center

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-25934

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.